Anthony D. Caracciolo

2017

In 2017, Anthony D. Caracciolo earned a total compensation of $422K as Executive Chairman at CytoDyn.

Compensation breakdown

Option Awards$352,273
Salary$69,750
Total$422,023

Caracciolo received $352.3K in option awards, accounting for 83% of the total pay in 2017.

Caracciolo also received $69.8K in salary.

Rankings

In 2017, Anthony D. Caracciolo's compensation ranked 12,447th out of 14,666 executives tracked by ExecPay. In other words, Caracciolo earned more than 15.1% of executives.

ClassificationRankingPercentile
All
12,447
out of 14,666
15th
Division
Manufacturing
4,899
out of 5,772
15th
Major group
Chemicals And Allied Products
1,794
out of 2,075
14th
Industry group
Drugs
1,492
out of 1,731
14th
Industry
Pharmaceutical Preparations
1,155
out of 1,333
13th
Source: SEC filing on July 24, 2017.

Caracciolo's colleagues

We found two more compensation records of executives who worked with Anthony D. Caracciolo at CytoDyn in 2017.

2017

Nader Pourhassan

CytoDyn

Chief Executive Officer

2017

Michael Mulholland

CytoDyn

Chief Financial Officer

In-depth

You may also like